← Back to Discover
Velan Capital Investment Management LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $164,207,527
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- PRAXIS PRECISION MEDICINES I · COM NEW · 74006W207 · shares: $29,722,991
- MAPLIGHT THERAPEUTICS INC · COM · 56565P103 · shares: $17,665,285
- SUTRO BIOPHARMA INC · COM SHS · 869367201 · shares: $17,003,712
- IMMIX BIOPHARMA INC · COM · 45258H106 · shares: $11,186,350
- PROTARA THERAPEUTICS INC · COM STK · 74365U107 · shares: $10,866,571
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $8,745,854
- TENAX THERAPEUTICS INC · COM NEW · 88032L605 · shares: $8,002,282
- ANTERIS TECHNOLOGIES GLOBAL · COM · 03675P102 · shares: $6,895,000
- EDESA BIOTECH INC · COM NEW · 27966L306 · shares: $6,727,575
- EVOMMUNE INC · COM SHS · 30054Y107 · shares: $5,997,179
Reported holdings
53 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 88,781 shares | $29,722,991 |
| MAPLIGHT THERAPEUTICS INC | COM | 56565P103 | — | 492,893 shares | $17,665,285 |
| SUTRO BIOPHARMA INC | COM SHS | 869367201 | — | 512,160 shares | $17,003,712 |
| IMMIX BIOPHARMA INC | COM | 45258H106 | — | 1,085,000 shares | $11,186,350 |
| PROTARA THERAPEUTICS INC | COM STK | 74365U107 | — | 2,844,652 shares | $10,866,571 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 65,630 shares | $8,745,854 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | — | 549,985 shares | $8,002,282 |
| ANTERIS TECHNOLOGIES GLOBAL | COM | 03675P102 | — | 700,000 shares | $6,895,000 |
| EDESA BIOTECH INC | COM NEW | 27966L306 | — | 827,500 shares | $6,727,575 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 324,452 shares | $5,995,873 |
| EVOMMUNE INC | COM SHS | 30054Y107 | — | 446,255 shares | $5,930,729 |
| XENCOR INC | COM | 98401F105 | — | 255,000 shares | $4,105,500 |
| REZOLUTE INC | COM NEW | 76200L309 | — | 750,000 shares | $3,900,000 |
| HERON THERAPEUTICS INC | COM | 427746102 | — | 8,753,290 shares | $3,735,904 |
| VERRICA PHARMACEUTICALS INC | COM SHS | 92511W207 | — | 471,559 shares | $2,885,941 |
| C4 THERAPEUTICS INC | COM STK | 12529R107 | — | 570,000 shares | $2,661,900 |
| EUPRAXIA PHARMACEUTICALS INC | COM | 29842P105 | — | 352,000 shares | $2,326,720 |
| ADMA BIOLOGICS INC | COM | 000899104 | — | 250,000 shares | $2,092,500 |
| REIN THERAPEUTICS INC | COM NEW | 00887A204 | — | 1,700,000 shares | $1,768,000 |
| LYELL IMMUNOPHARMA INC | COM NEW | 55083R203 | — | 105,000 shares | $1,475,250 |
| NASUS PHARMA LTD | ORD SHS | M7071P109 | — | 359,390 shares | $1,257,865 |
| PROFOUND MED CORP | COM NEW | 74319B502 | — | 170,278 shares | $1,132,349 |
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | — | 2,423,067 shares | $1,020,111 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | CALL | 68,700 shares | $999,585 |
| PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | — | 3,700 shares | $453,546 |
| CYTOMX THERAPEUTICS INC. | COM | 23284F105 | — | 120,000 shares | $450,000 |
| NEUMORA THERAPEUTICS INC. | COM | 640979100 | — | 230,000 shares | $391,000 |
| NURIX THERAPEUTICS INC | COM | 67080M103 | — | 16,000 shares | $388,160 |
| OVID THERAPEUTICS INC | COM | 690469101 | — | 130,000 shares | $349,700 |
| PRECISION BIOSCIENCES INC | COM NEW | 74019P207 | — | 40,000 shares | $314,400 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 11,000 shares | $296,780 |
| MACROGENICS INC | COM | 556099109 | — | 60,000 shares | $277,200 |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | — | 26,000 shares | $243,880 |
| ARTIVA BIOTHERAPEUTICS INC | COM | 04317A107 | — | 25,000 shares | $242,500 |
| REPLIMUNE GROUP INC | COM | 76029N106 | — | 20,000 shares | $221,400 |
| SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | — | 10,000 shares | $218,600 |
| IMMUNOME INC | COM | 45257U108 | — | 10,000 shares | $211,900 |
| TECTONIC THERAPEUTIC INC | COM | 878972108 | — | 6,000 shares | $206,250 |
| ROCKET PHARMACEUTICALS INC | COM | 77313F106 | — | 60,000 shares | $205,200 |
| KARYOPHARM THERAPEUTICS INC | COM NEW | 48576U205 | — | 20,000 shares | $195,400 |
| AN2 THERAPEUTICS INC | COM | 037326105 | — | 40,000 shares | $193,600 |
| VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | — | 10,000 shares | $183,700 |
| SCYNEXIS INC | COM | 811292309 | — | 40,000 shares | $162,800 |
| QUOIN PHARMACEUTICALS LTD | SPONSORED ADS | 74907L409 | — | 32,372 shares | $156,680 |
| XILIO THERAPEUTICS INC | COM | 98422T209 | — | 14,285 shares | $136,850 |
| INSPIREMD INC | COM | 45779A846 | — | 148,138 shares | $103,711 |
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | — | 245,328 shares | $103,283 |
| KALARIS THERAPEUTICS INC | COM | 482929106 | — | 25,000 shares | $101,750 |
| LARIMAR THERAPEUTICS INC | COM | 517125100 | — | 33,000 shares | $100,650 |
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | — | 45,000 shares | $83,700 |
| EVOMMUNE INC | COM SHS | 30054Y107 | — | 5,000 shares | $66,450 |
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | — | 59,700 shares | $33,068 |
| GOSSAMER BIO INC | COM | 38341P102 | — | 70,000 shares | $11,522 |